Why It Matters
The Antiphospholipid Panel evaluates antibodies and clotting abnormalities associated with Antiphospholipid Syndrome (APS), an autoimmune condition that increases the risk of abnormal blood clots and pregnancy complications. Accurate identification of APS is critical because symptoms may remain undetected until serious thrombotic events or recurrent pregnancy loss occur.
Who Should Get It
Recommended for individuals with unexplained blood clots, recurrent miscarriage, stroke at a young age, autoimmune disease such as lupus, or history of pregnancy complications associated with clotting disorders. It is also useful for patients with suspected autoimmune-related thrombosis.
How This Panel Is Used
Physicians use the Antiphospholipid Panel to evaluate suspected APS, investigate unexplained thrombotic events, assess pregnancy-related clotting complications, and support autoimmune clotting risk assessment. It is commonly ordered during hematologic, rheumatologic, and reproductive evaluations.
What’s Included
This panel includes antiphospholipid antibodies and functional clotting assays associated with autoimmune-mediated thrombosis and pregnancy complications. Together, these biomarkers help support accurate detection and clinical evaluation of Antiphospholipid Syndrome.
Together, these biomarkers provide a focused evaluation of autoimmune-related clotting risk, supporting accurate assessment of Antiphospholipid Syndrome and related thrombotic complications.